Tyvaso significantly improved a measure of lung function for IPF patients in a Phase 3 trial, which top-line data showed met ...

September is Pulmonary Fibrosis Awareness Month, and advocates are hoping to call attention to the condition and interstitial ...

Columnist Sam Kirton discusses the growth of the Pulmonary Fibrosis Foundation with the organization's president, Scott Staszak.

Days before embarking on an overseas trip, columnist Sam Kirton makes his final preparations, including getting the OK from his care team.

Rein is working to begin U.K. enrollment for its Phase 2 trial of LTI-03, a candidate therapy for IPF, after receiving regulatory approval.

Columnist Sam Kirton takes readers on his journey from a pulmonary function test to his results from lung biopsies that weren't routine.

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.

The U.S. Food and Drug Administration has granted Bristol Myers Squibb’s investigational therapy BMS-986278 breakthrough therapy status.

A study found 10 IPF patients given EGCG, a green tea antioxidant, for 14 days had normal levels of pro-fibrotic proteins in lung tissue.

One of my frustrations as a pulmonary fibrosis patient is finding solid information about what to expect as my PF progresses. I’ve asked several doctors what to expect during the end stage of PF, but ...

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.

Clinical trials are in-human studies aimed at gathering a variety of information about different aspects of disease and health conditions. Many clinical trials are designed to evaluate the safety and ...